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The Dynamics of Dendritic Cell―
Mediated Innate Immune Regulation
Toshiaki Ohteki1
ABSTRACT
After taking up pathogen-derived antigens, dendritic cells (DCs) leave peripheral organs and migrate into senti-
nel lymph nodes via afferent lymphatic vessels. During this process, they undergo maturation and produce
proinflammatory cytokines, which leads to efficient antigen (Ag) presentation and activation of the innate and
acquired immune systems. Recent evidence indicates that DC subsets cooperate to activate the innate im-
mune system. It is becoming clear that the total DC population is composed of a network of DC subsets with
distinct functions that are critical for sensing pathogens and orchestrating immune responses.
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INTRODUCTION
Pathogenic infection-derived immune activation con-
sists of a series of responses, which include Ag up-
take by sensor receptors expressed on DCs, Ag proc-
essing, DC maturation, chemokine-dependent migra-
tion of DCs to the T-cell regions of sentinel lymph
nodes (LNs), presentation of processed Ags, and T-
cell activation. The maturation stimulus for DCs af-
fects the outcome of the immune response; e.g., the
stimulus can promote the differentiation of naive
CD4+T cells into T helper type 1 (Th1), Th2, Treg, or
Th17 cells. In mice, the CD8α+ and CD8α− DC sub-
sets appear to have different properties for secreting
IL-12 p70,1-4 a critical cytokine for Th1 differentiation.
In contrast, in both humans and mice, plasmacytoid
dendritic cells (pDCs) are a specialized population of
cells that produce interferon (IFN)-α, a critical cy-
tokine for the activation of NK cells and CTLs, and for
B-cell differentiation into antibody-producing plasma
cells.5,6 In this review, following a brief summary of
how DCs regulate the activation of the innate im-
mune system, I will concentrate on the cooperative
properties of DC subsets in responding to viral infec-
tion and in the stimulation of the Toll-like receptor
(TLR) ligand.
SENSORS FOR ANTIGEN UPTAKE AND
RECOGNITION
The epithelium of the skin and the mucosa physically
block pathogens from invading the body, and DCs
are positioned as a second line of defense beneath
the epithelial layer, without exception. For instance,
Langerhans cells (LCs) in the skin lie in the supraba-
sal layer,7 DCs in the intestine are positioned beneath
the epithelium and extend their dendrites through
epithelial junctions to take up luminal Ags,8-10 and in
Peyer’s patches, tonsils, and nasal-associated lym-
phoid tissue (NALT), DCs are found just below the
antigen-transporting M cells.11-13 Once infection oc-
curs, DCs take up pathogen-associated Ags through
C-type lectin and Fc receptors.14,15 The Toll-like re-
ceptors (TLRs) are a family of pattern-recognition re-
ceptors that detect structural components shared by
bacteria, viruses, and fungi.16,17 However, in contrast
to the C-type lectin and Fc receptors, TLRs do not
take up such components; instead, they deliver sig-
nals to produce proinflammatory cytokines.
C-type lectins are either produced as transmem-
brane proteins or secreted as soluble proteins. Some
membrane-bound forms of the C-type lectins are ex-
pressed on DCs (Fig. 1).14,15 The macrophage man-
nose receptor (MMRCD206), the prototype of this
family, recognizes mannose and fucose not only on a
range of bacteria, viruses, and yeast, but also on cer-
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Fig. 1 C-type lectins and FcγR on DCs. MMR and DC-SIGN bind mannose 
and fucose on pathogens, Dectin-1 binds β-glucan, and FcγR binds immune 
complex. Natural ligands for the other C-type lectins remain largely unknown. 
In addition, DCAR and Dectin-2 form a complex with FcγR and deliver signals. 
P, proline-rich regions; ITIM, immuno-receptor tyrosine based inhibitory motif; 
ITAM, immuno-receptor tyrosine based activation motif.
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tain endogenous glycoproteins, such as lysosomal hy-
drolases.18 Similarly, DC-specific ICAM-3-grabbing
non-integrin (DC-SIGNCD209) binds the mannose
and fucose on a variety of pathogens, including hu-
man immunodeficiency virus (HIV-1).14 DEC205
CD205 is a DC-specific C-type lectin, and its cytoplas-
mic tail contains motifs critical for intracellular target-
ing and for recycling between the cell surface and the
endosome, where MHC class II molecules are con-
centrated.19 Thus, an anti-DEC205 antibody that is ar-
tificially tagged with a certain Ag activates the ma-
chinery for MHC class II-dependent Ag presentation
and promotes CD4+T-cell activation. The natural
ligands of the other C-type lectins, including
Langerin, DCAR, DCIR, dectin-2, and BDCA-2, re-
main unknown.14,15 Importantly, the TLRs and C-type
lectins function cooperatively, which seems to be re-
quired for optimal DC activation.20,21 In addition to
the C-type lectins, DCs express FcγR, which takes up
immune complexes and presents these antigens on
MHC classes I and II.
DC TRAFFICKING TO LYMPH NODES
Upon taking up pathogen-derived foreign antigens,
DCs begin to express a lymph node-homing
chemokine receptor, CCR7, which enables the DCs
to enter afferent lymphatic vessels and migrate into
lymph nodes, where CCL19 and CCL21, the ligands
for CCR7, are expressed.22 Consistent with this sce-
nario, the transfer of CCR7−− DCs into wild-type mice
severely reduces the number of DCs recovered from
the lymph nodes compared with the transfer of
CCR7++ DCs.23 Consistent with the idea that CCR7 is
important for DC trafficking, in the plt mouse, a natu-
rally occurring mutant that lacks the genes for CCL19
and CCL21, DC trafficking to the lymph nodes is im-
paired.24
REQUIREMENTS FOR T-CELL ACTIVATION
To activate naive T cells in the sentinel lymph nodes
efficiently, DCs must mature by the time they arrive
there. It is well known that DC maturation is medi-
ated by proinflammatory cytokines such as TNF-α,
and by TLR- and CD40L-dependent signals.25-28 The
definition of mature DCs is closely related to their ca-
pacity to activate T cells, which is mediated by signals
1, 2, and 3.29 Signal 1 is delivered through the T-cell
receptor (TCR), by its engagement of the MHCanti-
genic peptide complex. Signal 2 is referred to as
“costimulation,” and is typically delivered through
CD28 on T cells, by its engagement of CD8086. To-
gether with signal 1, signal 2 initiates acquired immu-
nity, such as T-cell clonal expansion and differentia-
tion into effector cells. Signal 3 is delivered from DCs
to T cells and determines the fate of T cells (Fig. 2).
For example, IL-12 is one of the signal 3 mediators
and, in cooperation with IFN-α, induces naive T-cell
differentiation into Th1 cells and induces cytotoxic ac-
tivity of and IFN-γ production by NK cells and
CTLs.29 Another example is the expression of notch
family members on DCs. Delta-1 induces differentia-
tion to Th1, whereas jagged-2 initiates Th2 differen-
DCs in Innate Immune Regulation
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Fig. 2 DC-derived cytokines control the fate of T cels. IL-
12, the notch family member Delta-1, T-bet, and semaphorin 
4A induce naive T-cel diferentiation into Th1 cels, whereas 
jagged-2 initiates Th2 diferentiation. Other DC-derived cyto-
kines, TGF-β and IL-2, induce Treg diferentiation, whereas 
TGF-β and IL-6 are essential for Th17 diferentiation. IL-6 
suppresses Treg diferentiation.
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tiation.30,31 Other molecules including T-bet and
semaphorin 4A are also involved in Th1 differentia-
tion.32
In addition to Th1 and Th2 cells, it was recently
shown that Th17 cells are critically involved in some
autoimmune diseases, such as experimental autoim-
mune encephalomyelitis (EAE), collagen-induced ar-
thritis (CIA), and experimental autoimmune uveo-
retinitis (EAU).33 In contrast, regulatory T cells
(Treg) are essential for the maintenance of peripheral
immune tolerance. Of note, the DC-derived cytokines
TGF-β and IL-2 induce Treg differentiation, whereas
TGF-β and IL-6 are essential for Th17 differentiation
(Fig. 2). In this context, Treg differentiation is sup-
pressed in the presence of IL-6 (Fig. 2).34
DC SUBSETS AND IMMUNE ACTIVATION
In the lymph nodes, where DCs prime T cells, both
blood-derived and tissue-derived DCs are present.
The former are derived from bone marrow and are
delivered via the peripheral blood, and the latter ar-
rive there by immigration via afferent lymphatic ves-
sels after taking up Ags. The blood-derived DCs can
be divided into two subpopulations, conventional DCs
(cDCs) and pDCs. Based on the expression pattern
of surface markers, including CD4, CD8, CD11b, and
DEC205 (CD205), the cDCs can be further divided
into multiple subsets.35 CD8α+ DCs are CD4−CD8α+
CD205+ CD11blow, whereas CD4+ DCs are CD4+
CD8α−CD205−CD11bhigh. Another blood-derived DC
subset is double-negative (DN) DCs, which are CD4−
CD8α−CD205−CD11bhigh. The three blood-derived
DC subsets appear to develop in lymphoid organs
from pre-DC precursors generated in the bone mar-
row.
On the other hand, the pDCs are specifically re-
sponsible for IFN-α production, and are characterized
by the expression of surface markers CD123 (IL-3R),
BDCA-2, and BDCA-4 in humans, and Ly6c, B220,
120G8, and mPDCA-1 in mice.5,6 A pDC’s ability to
produce IFN-α depends on its expression of sensor
receptors TLR7 and TLR9.36-39 TLR7 mediates the
recognition of ribonucleotide homologs, including
loxoribine, synthetic single stranded (ss) RNA, and
RNA viruses, whereas TLR9 is a receptor for CpG,
which is prevalent in bacteria and DNA viruses.
TLR79 ligation in pDCs activates the formation of a
complex consisting of MyD88, IRAK4, IRAK-1,
TRAF6, IRF-7, TRAF3, IκB kinase-α, and osteopontin,
which leads to IFN-α production.40-46 In cooperation
with IL-12, pDC-derived IFN-α induces the cytotoxic
activity of and IFN-γ production by NK cells and
CTLs, and the differentiation of Th1 cells. In coopera-
tion with IL-6, the IFN-α also affects B-cell differentia-
tion into antibody-producing plasma cells. pDC-
derived IFN-α plays a critical role in antiviral immu-
nity by inducing the differentiation of effector lym-
phocytes, but also participates in the pathogenesis of
systemic lupus erythematosus by promoting B-cell
differentiation into autoantibody-producing plasma
cells (Fig. 3).5,6
CROSSTALK BETWEEN DC SUBSETS
Many in vitro and in vivo studies have clearly demon-
strated distinct functions for each DC subset, as de-
scribed above. However, these functions alone cannot
always explain immune responses, which are actually
part of a complex network; rather, the situation may
best be described as a “division of labor” among DC
subsets. Inter-DC Ag-transfer is one example.35,47-49
Upon taking up pathogen-derived foreign Ags, the
tissue-derived DCs migrate into lymph nodes and
transfer the Ags to the resident CD8α+DCs, termed
inter-DC Ag-transfer, rather than directly to CD8+T
cells. As a result, Ags are mainly cross-presented by
the CD8α+DCs to CD8+T cells. Several mechanisms
for inter-DC Ag-transfer have been proposed, includ-
ing 1) direct interaction of tissue-derived DCs with
CD8α+DCs, 2) secretion of exosomes containing the
Ag by tissue-derived DCs, and 3) the incorporation of
tissue-derived apoptotic DCs by CD8α+DCs. Another
example of DC “division of labor” was shown in a re-
cent study of herpes simplex virus type-1 (HSV-1) in-
fection. The DNA genomes of HSV-1 are detected by
Toll-like receptor 9 (TLR9); subsequently, pDCs are
recruited to the lymph nodes and generate anti-HSV-
1 CTLs in cooperation with cDCs.50 Further analysis
revealed that the LN cDCs form clusters with T cells
only in the presence of pDCs, and induce CTLs.
pDCs provide licensing signals to cDCs by express-
ing CD2 and CD40L, and pDC-derived IFN-α further
promotes the differentiation of CD8+T cells into HSV-
1-specific CTLs (Fig. 4).
We have also shown the importance of collabora-
tive action between cDCs and pDCs for the innate re-
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Fig. 3 Roles of pDC-derived IFN-α in infection and autoimmune 
disease. In viral infections, pDC-derived IFN-α induces the diferentiation 
of CTLs, Ab-producing plasma cels, and the maturation of DCs. IFN-α can 
also function in the pathogenesis of systemic lupus erythematosus by pro-
moting B-cel diferentiation into autoantibody-producing plasma cels.
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Fig. 4 Crosstalk between DC subsets. CpG binds TLR9 to 
stimulate DCs to produce IL-15. IL-15 induces CD40 expres-
sion on cDCs. CD40 interacts with CD40L expressed on 
pDCs and leads to IL-12 production. In HSV-1 infection, 
CD40 and CD58 on cDCs bind CD40L and CD2 on pDCs, 
respectively. Such interactions, combined with the elabora-
tion of DC-derived IL-12 and IFN-α, are critical for the induc-
tion of HSV-1-specific CTL.
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sponses to synthetic CpG DNA, a representative TLR
ligand.51 Under physiological conditions, TLR9 is lo-
cated intracellularly in vesicles, and CpG is trans-
ported into these vesicles by endocytosis.52-54 Inside
the vesicles, CpG binds TLR9, and the subsequent re-
cruitment of the myeloid differentiation primary re-
sponse gene 88 (MyD88)-adaptor protein results in
the initiation of the TLR signaling cascade.52-54 Ulti-
mately, activating protein 1 (AP-1) and NF-κB tran-
scription factors enter the nucleus and activate a vari-
ety of inflammatory genes. The end result is that CpG
stimulates DC activation by promoting antigen pres-
entation, co-stimulatory molecule expression, and
proinflammatory cytokine production, e.g., large
quantities of IL-12, a strong inducer of Th1-mediated
immune activation.52-54
Using an established model of Listeria monocyto-
genes (LM) infection, we initially found that DC-
derived IL-15 is essential for the CpG-mediated activa-
tion of protective immune responses in vivo. To ex-
amine whether cDCs and pDCs have distinct roles in
CpG-induced IL-15 production and the subsequent
immune responses, we selectively depleted pDCs in
vivo by injecting anti-mPDCA-1. Interestingly, the re-
sults clearly showed that cDCs are the major source
of both IL-15 and IL-12, and that cDCs fail to produce
IL-12 in the absence of pDCs, which suggests cros-
stalk between cDCs and pDCs. To investigate
whether cDC-derived IL-15 acts on cDCs or pDCs,
both DC subsets were isolated from WT and
Il15rα−− mice 24 h after CpG injection, and were co-
cultured in vitro in the presence of CpG. WT cDCs
co-cultured with WT or Il15rα−− pDCs produced sub-
stantial amounts of IL-12, whereas Il15rα−− cDCs co-
cultured with WT or Il15rα−− pDCs produced little, if
DCs in Innate Immune Regulation
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any, IL-12, indicating that the cDC-derived IL-15 prob-
ably acts on the cDCs themselves. These findings im-
ply that cDC-derived IL-15 induces the expression of
critical molecule(s) on cDCs that interact with pDCs.
In this context, we found that cDC-derived IL-15 in-
duces CD40 expression on cDCs, which interacts
with CD40L on pDCs, finally leading to IL-12 p70 pro-
duction from cDCs (Fig. 4).
CONCLUSIONS
Numerous cooperative interactions are necessary for
optimal immune activation. For example, crosstalk
between T cells, B cells, and Ag-presenting cells is
important for the effective eradication of pathogens.
We propose that important crosstalk also occurs be-
tween DC subsets. Furthermore, the crosstalk may
be critical for the induction, not only of immune acti-
vation against foreign Ags, but also of tolerance to-
wards self-Ags. How the DC subsets recognize
whether an Ag is derived from non-self or self and
how DC crosstalk is involved in these processes re-
main important issues for future studies.
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